Linus Biotechnology
LinusBio is a pioneering platform company developing precision exposome biomarkers to enable earlier diagnoses, enhance patient monitoring, and accelerate drug development, especially in complex conditions like autism spectrum disorder, ALS, and other neurological and complex diseases.
Industries
Nr. of Employees
small (1-50)
Products
Hair-based biochemical screening test for autism (diagnostic aid)
A laboratory-performed, non-genetic biochemical screening intended to help health care providers rule out autism in children (intended age range reported as 1–48 months in public materials). The assay analyzes a single hair strand to map time-resolved biochemical patterns and applies an algorithm to assess likelihood of ASD; results are provided by a CLIA-certified laboratory and the test must be ordered by a licensed provider (Rx-only as reported).
Hair-based biochemical screening test for autism (diagnostic aid)
A laboratory-performed, non-genetic biochemical screening intended to help health care providers rule out autism in children (intended age range reported as 1–48 months in public materials). The assay analyzes a single hair strand to map time-resolved biochemical patterns and applies an algorithm to assess likelihood of ASD; results are provided by a CLIA-certified laboratory and the test must be ordered by a licensed provider (Rx-only as reported).
Services
Platform access for clinical trials and biomarker discovery
Provision of temporal exposomic sequencing and analytical services to support biomarker discovery, pathway characterization, and use as molecular endpoints in clinical trials.
CLIA-regulated laboratory diagnostic testing
Laboratory testing services performed in a CLIA-certified facility using hair-derived exposomic assays to generate clinically reportable results for provider-ordered diagnostic aids.
Partnerships and collaborative research programs
Structured collaborations with advocacy groups, care platforms, industry partners, and academic investigators to expand access, research use, and clinical validation of exposomic biomarkers.
Medical information and clinician support
Medical information request and clinician support services to respond to healthcare professional inquiries about tests, data, and clinical usage.
Platform access for clinical trials and biomarker discovery
Provision of temporal exposomic sequencing and analytical services to support biomarker discovery, pathway characterization, and use as molecular endpoints in clinical trials.
CLIA-regulated laboratory diagnostic testing
Laboratory testing services performed in a CLIA-certified facility using hair-derived exposomic assays to generate clinically reportable results for provider-ordered diagnostic aids.
Partnerships and collaborative research programs
Structured collaborations with advocacy groups, care platforms, industry partners, and academic investigators to expand access, research use, and clinical validation of exposomic biomarkers.
Medical information and clinician support
Medical information request and clinician support services to respond to healthcare professional inquiries about tests, data, and clinical usage.
Expertise Areas
- Precision exposomics
- Biomarker discovery and validation
- Mass spectrometry-based analytics
- Laboratory automation and scale-up
Key Technologies
- Temporal exposome sequencing
- Hair-based temporal sampling
- Laser-based sample extraction
- High-resolution mass spectrometry